Form 4: CVS Health Director Acquires Deferred Stock Units
SEC Form 4 Filing
CVS Health director Alecia A. DeCoudreaux acquired 2,200.0876 deferred stock units, convertible to common stock, as part of a semi-annual retainer.
Summary
- Alecia A. DeCoudreaux, a director at CVS Health Corp, reported a transaction on November 21, 2024.
- The transaction involved the acquisition of 2,200.0876 deferred stock units.
- These units were issued as part of a semi-annual retainer under the company's non-employee director compensation policy.
- The deferred stock units are valued at the market price and will be converted into common stock in the future, as elected by the reporting person.
- Following the transaction, Ms. DeCoudreaux beneficially owns 34,934.2665 shares of common stock.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to director compensation, which is generally neutral to positive. The acquisition of stock units aligns the director's interests with the company's performance.
Positives
- The acquisition of deferred stock units aligns the director's interests with the company's performance.
- The transaction is part of a standard compensation policy for non-employee directors.
Future Outlook
The deferred stock units will be converted into common stock in the future, as elected by the reporting person.
Industry Context
This is a routine filing related to director compensation and is common practice for publicly traded companies.
Comparison to Industry Standards
- Director compensation packages often include deferred stock units to align director interests with shareholder value, this is a common practice among S&P 500 companies.
- Companies like Walgreens Boots Alliance (WBA) and UnitedHealth Group (UNH) also use similar compensation structures for their non-employee directors.
- The value of the deferred stock units is consistent with market rates for director compensation in the healthcare sector.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns director interests with company performance.
Next Steps
- The deferred stock units will be converted into common stock at a future date, as elected by the reporting person.
Key Dates
| Date | Description |
|---|---|
| 11/21/2024 | Date of the transaction where deferred stock units were acquired. |
| 11/25/2024 | Date the Form 4 was signed. |
Keywords
CVS Health, Director, Deferred Stock Units, Stock Acquisition, Form 4, Insider Trading, Compensation, Non-Employee Director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.